Is Global Partners LP (GLP) The Best Pipeline and MLP Stock to Invest In According to Analysts?
We recently published a list of 10 Best Pipeline and MLP Stocks to Invest In According to Analysts. In this article, we are ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Jumping Into The FDA Gamble: Initiating Hims & Hers With A Buy
Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...
Medscape7d
The End of Compounded GLP-1s: What Physicians Need to Know
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
JD Supra2h
The GLP-1 Coverage Conundrum: Managing Costs for Group Health Plans
Many employers are facing challenges in incorporating high-cost GLP-1 medications, such as Mounjaro, Ozempic, Rybelsus, Trulicity, and Wegovy, ...
Endocrinology Advisor1d
GLP-1 Drugs Associated With a Reduced Risk of Multiple Age-Related Ocular Diseases
Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.
Healio3d
Societies take stand against off-brand GLP-1s over safety concerns
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
BioSpace1d
GLP-1 Drug Boom Recalls the Rise of PD-1 Checkpoint Inhibitors
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
Yahoo Finance2d
Is Global Partners (GLP) One of the Best Pipeline and MLP Stocks to Invest In According to Analysts?
We recently published a list of 10 Best Pipeline and MLP Stocks to Invest In According to Analysts. In this article, we are going to take a look at where Global Partners LP (GLP) stands against ...